Cangrelor ameliorates CLP-induced pulmonary injury in sepsis by inhibiting GPR17

BACKGROUND: Sepsis is a common complication of severe wound injury and infection, with a very high mortality rate. The P2Y12 receptor inhibitor, cangrelor, is an antagonist anti-platelet drug. METHODS: In our study, we investigated the protective mechanisms of cangrelor in CLP-induced pulmonary inju...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Med Res
Egile Nagusiak: Luo, Qiancheng, Liu, Rui, Qu, Kaili, Liu, Guorong, Hang, Min, Chen, Guo, Xu, Lei, Jin, Qinqin, Guo, Dongfeng, Kang, Qi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262027/
https://ncbi.nlm.nih.gov/pubmed/34229761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40001-021-00536-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak